M&A Deal Summary |
|
---|---|
Date | 2015-04-22 |
Target | DriveFactor |
Sector | Technology Hardware |
Buyer(s) | Safeguard |
Deal Type | Add-on Acquisition |
Deal Value | 22M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Sector | Financial Services |
Employees | 30 |
Revenue | 6M USD (2023) |
Safeguard is a provider of capital and operational expertise to emerging and growth-stage healthcare and technology enterprises that are developing innovative products and services.
DEAL STATS | # |
---|---|
Overall | 9 of 10 |
Sector (Technology Hardware) | 1 of 1 |
Type (Add-on Acquisition) | 3 of 4 |
State (Vermont) | 1 of 1 |
Country (United States) | 9 of 10 |
Year (2015) | 1 of 2 |
Size (of disclosed) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-02-04 |
Crescendo Bioscience
South San Francisco, California, United States Crescendo Bioscience, Inc. is a molecular diagnostics company dedicated to developing and commercializing quantitative blood tests for rheumatoid arthritis (RA) and other autoimmune diseases. |
Sell | $270M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-12-01 |
Zipnosis
Minneapolis, Minnesota, United States Zipnosis is a design technology healthcare company enabling traditional care models with an adaptive telemedicine solution that reduces costs, improves outcomes, and creates happier patients. Zipnosis evolves healthcare ecosystems and focused on innovation that improves the human experience for patients, providers, and healthcare organizations. Zipnosis was founded in 2008 and is based in Minneapolis, Minnesota. |
Buy | - |